Positive results from its Type 2 diabetes trial have already been announced
INN does not endorse or recommend the business, products, services or securities of any company profiled
11 Perna et al reported that in obese elderly patients receiving 24 weeks of treatment with liraglutide, there was a significant reduction in fat mass, but no reduction in appendicular lean mass
Preclinical evidence is accumulating, and translational research is highly required to increase knowledge on the effect of GLP-1 on reward systems
31 Intranasal administration of Semax at 16 mg/kg in healthy adults improved decision-making, work site performance, mental acuity, short-term memory, and attention span, with results lasting up to 24 hours